Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shortages Are A Matter Of Time As Bill Sponsors Work To Show Warnings Will Help

Executive Summary

Supporters of pending legislation on drug shortages face a challenge of time – demonstrating that the extra time the advance-warning system would provide is worth the legislative time and effort to create it.
Advertisement

Related Content

To Prevent Drug Shortages, Don't Look To Inspections, FDA Says
Inspection Improvements Could Help Fight Drug Shortages, Hospital Group Says
What’s In A PDUFA Reauthorization? Maybe These Issues…
What’s In A PDUFA Reauthorization? Maybe These Issues…
Not Another FDAAA – Observers Expect Fewer FDA Reforms In PDUFA V
In Brief
In Brief
Drug Shortage Legislation Gains Momentum With Bipartisan House Bill

Topics

Advertisement
UsernamePublicRestriction

Register

PS053591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel